Periodontal Therapeutics Market Forecasts to 2028 – Global Analysis By Type (Gingivitis, Chronic Periodontitis), Product (Devices, Drugs), End User, and By Geography

Periodontal Therapeutics Market Forecasts to 2028 – Global Analysis By Type (Gingivitis, Chronic Periodontitis), Product (Devices, Drugs), End User, and By Geography

According to Stratistics MRC, the Global Periodontal Therapeutics Market is accounted for $691.35 million in 2021 and is expected to reach $1,417.35 million by 2028 growing at a CAGR of 10.8% during the forecast period. Periodontitis is a chronic bacterial infection caused because of microbial plaque known as gum disease, which is colonized on the tooth surface and below the gingival margin. Periodontitis can lead to tooth loss and is a risk factor for heart and lung diseases. Periodontal therapeutics is a non-surgical treatment for periodontal diseases.

People are focusing on oral hygiene more than ever before because of the rising prevalence of dental caries. According to World Health Organization, more than 3.5 billion people suffer from oral diseases. Untreated dental caries (tooth decay) in permanent teeth are the most common. Severe periodontal (gum) disease affects almost 10% of the global population and more than 530 million children suffer from dental caries of primary teeth. The growing awareness regarding the importance of maintaining oral hygiene has led to a rise in expenditure on dental healthcare, which is augmenting the oral care market.

Market Dynamics:

Driver:

Increasing awareness about oral health

Oral health programs work for the formulation of national and community policies on effective control of diet and nutrition risk factors for oral diseases. Periodontal diseases have a significant socio-economic impact on populations and governments across the world; however, treatment for these diseases still stays unavailable in emerging countries because of the low priority accorded to these diseases. Projects are launched to reduce the overall global burden of periodontal diseases. The project aims to decrease the burden related to these diseases by raising awareness of their impact and engaging oral health and other health professionals, policymakers, educators, and the general public in promoting periodontal health.

Restraint:

High cost

The dental methodology is often seen as costlier as the more particular the dental care becomes the more modern and trained the dental team should be to provide a high quality of service for techniques. Advanced dental and periodontal procedures turn out to be too expensive for an average citizen in both developed and developing countries. Also, the government mandates and interventions lead to an increase in the cost of care. High cost or expensive surgery has become the biggest issue the periodontal service providers and is restraining the market growth.

Opportunity:

Increasing therapeutic advancements

The burden of periodontal diseases has guided different leading market players to build their research and development for periodontal therapeutics. Research and development for new high-level periodontal therapeutics are likely to increase the adoption of periodontal therapeutics for the treatment of periodontal disease. Currently, many manufacturers are in the improvement stage and few have already launched clinical trials for periodontal therapeutics which is likely to fulfill demand and create new opportunities for the periodontal therapeutics market.

Threat:

Uninsured dental care in several developed and developing countries

Oral health care coverage is seen to be low in low- and middle-income countries. Dental care is not insured in several developed countries such as Canada and the U.S. In the U.S., only the most rudimentary dental care is covered by health insurance plans, which is acting as a major challenge to the growth of the market.

The hospitals segment is expected to be the largest during the forecast period

The hospitals segment is estimated to have a lucrative growth owing to the huge number of patient footfall in addition to a high number of surgeries that take place in such places, availability of developed and latest infrastructure, and rising investments to develop infrastructure, skilled professionals and easy accessibility.

The chlorhexidine segment is expected to have the highest CAGR during the forecast period

The chlorhexidine segment is anticipated to witness the fastest CAGR growth during the forecast period as the use of chlorhexidine mouthwashes is an excellent way to maintain and treat mild forms of gum disease. Chlorhexidine gluconate is a prescription antiseptic used in dentistry to fight bacteria found in the oral cavity that contributes to gum disease.

Region with highest share:

Asia Pacific is projected to hold the largest market share during the forecast period due to an increase in the geriatric population, a rise in research & developmental activities, a surge in initiatives by governments in the health care sector, rise in interest in key players in expanding presence in the region, large patient population, and growing healthcare infrastructure and expenditure.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period owing to a rise in product approvals, well-established health care infrastructure, increase in technological advancements, rise in the number of well-equipped laboratories, surge in research & developmental activities in therapeutics, and presence of established market players. Moreover, other factors increasing the regional market share are the rise in healthcare expenditure, high level of drug development, high investment in R&D activities by key players, and presence of a proper regulatory framework for periodontal drugs.

Key players in the market

Some of the key players profiled in the Periodontal Therapeutics Market include Xttrium Laboratories, Inc, Valeant Pharmaceuticals International, Inc., Pfizer Inc, Dexcel Pharma, Oral Science, Kaken Pharmaceutical Co., Ltd., Den-Mat Holdings, LLC, Colgate Palmolive, Bausch Health, 3M Company, OraPharma Inc and Planmeca.

Key Developments:

In Feb 2022, OraPharma launched the OraFit™ custom clear aligner system, which is indicated for correcting malocclusion, which is also known as a crooked or misaligned permanent tooth. The new OraFit™ aligner system uses high-performance materials in a three-layer design that offers dental professionals and their patients the latest in clear aligner technology and addresses the increased demand for improved aesthetics, more comfortable aligners, and overall long-term oral health.

In March 2019, Planmeca introduced a Planmeca Creo™ C5. The powerful Planmeca Creo™ C5 brings fast, safe, and accurate 3D printing directly to the dental clinic. Its advanced LCD technology, innovative material capsules, and optimised settings make the printer an easy and reliable solution – just plug and print.

Types Covered:
• Necrotizing Periodontal Disease
• Gingivitis
• Chronic Periodontitis
• Aggressive Periodontitis

Products Covered:
• Devices
• Drugs

Patient Demographics Covered:
• Pediatric
• Geriatric
• Adults

Distribution Channels Covered:
• Retail Pharmacies
• Hospital Pharmacies
• E-Commerce/Online Pharmacies
• Drug Stores
• Dental Office

End Users Covered:
• Specialty Clinics
• Hospitals
• Homecare

Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
Comprehensive profiling of additional market players (up to 3)
SWOT Analysis of key players (up to 3)
• Regional Segmentation
Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances